Speeding Up Drug Approvals: A Health Risk?
In a surprising turn of events, the newly appointed head of the U. S. drug regulatory agency has expressed serious doubts about the recent push to fast-track drug approvals. This official, who just started their role this month, believes that these changes might not only be against the law but could